NCT00743860 A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848 Status COMPLETED Phase PHASE1
NCT00742352 PET FDG Assessment of Change in Atherosclerotic Plaques After Chemotherapy Status UNKNOWN Phase N/A
NCT00737919 The Influence of Dietary Plant Sterols and Plant Stanols on Cholesterol and Plant Sterol Levels in Atheromatous Plaques Status COMPLETED Phase NA
NCT00734123 Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Status UNKNOWN Phase PHASE4
NCT00734032 A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients Status COMPLETED Phase PHASE2
NCT00732576 Effects of Omega-3 Fatty Acids and Menaquinone-7 on Thrombotic Tendency Status COMPLETED Phase NA
NCT00732407 Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM) Status UNKNOWN Phase NA
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery Status COMPLETED Phase N/A
NCT00725868 Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention Status COMPLETED Phase NA
NCT00723320 Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis Status UNKNOWN Phase NA
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication Status COMPLETED Phase PHASE4
NCT00715169 Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease Status COMPLETED Phase PHASE2
NCT00712049 Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) Status UNKNOWN Phase PHASE4
NCT00704431 A Study With Darapladib to Collect Tolerability Information Status COMPLETED Phase PHASE1
NCT00695305 An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks Status COMPLETED Phase PHASE2